gantenerumab

alzheimers brain neurodegenerative memory head

Scientists reflect on Roche's Alzheimer's failure a year later

A year after Roche's Alzheimer’s drug failed a phase 3 trial, the data are being published, giving scientists a chance to reflect on what was learned.

Annalee Armstrong Nov 15, 2023 5:00pm

Fierce Biotech's Rotten Tomatoes of 2022

Dec 19, 2022 3:00am

part ways switch off track cancel end path

Roche thins Alzheimer's program after phase 3 failure

Dec 1, 2022 12:52pm

Eisai makes the case for lecanemab after 2nd patient death

Nov 29, 2022 7:50pm

path decision executive restructuring strategic

Roche Alzheimer's fail has industry circling the wagons

Nov 15, 2022 11:02am

Roche's anti-amyloid antibody fails phase 3 Alzheimer's trials

Nov 14, 2022 5:44am